Farther Finance Advisors »

Akebia Therapeutics shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.3k 5.2k 1.41
2025-12-31 $662 412 1.61
2025-09-30 $1.1k 412 2.73
2025-06-30 $1.5k 412 3.64
2025-03-31 $787 412 1.91

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard S&p 500 Etf Etf (VOO)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Dimensional International Value Etf Etf (DFIV)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Schwab U.s. Large-cap Etf Etf (SCHX)
Microsoft Corp Stock (MSFT)
Vanguard Value Etf Etf (VTV)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Amazon Stock (AMZN)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Ishares 0-5 Year Tips Bond Etf Etf (STIP)

View all positions for Farther Finance Advisors

Top funds holding Akebia Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Vanguard Capital Management
Geode Capital Management
Goldman Sachs Group
Renaissance Technologies
Qube Research & Technologies
Citigroup
Bank of America Corporation
Millennium Management
Northern Trust
Vanguard Portfolio Management
Charles Schwab Investment Management
Nantahala Capital Management

View all funds holding Akebia Therapeutics